P

Proacta

3 employees

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated “prodrugs” for the treatment of cancer.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical Device
Health Care

Date founded

2004

Funding rounds raised

Total raised

$35M

from 8 investors over 8 rounds

P

Proacta raised $35M on February 7, 2007

Investors: Delphi Ventures, GBS Venture Partners, No 8 Ventures, Clarus Ventures, LLC and Alta Partners

P

Proacta raised $7M on September 11, 2006

Investors: No 8 Ventures and GBS Venture Partners

P

Proacta raised $1.5M on July 26, 2004

Investors: GBS Venture Partners

FAQ